Technical Analysis for ERYP - Erytech Pharma S.A.
|Grade||Last Price||% Change||Price Change|
ERYP closed up 3.36 percent on Friday, January 18, 2019, on 3.24 times normal volume. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.
|Weak or Absent||Down||Up||Up|
|See historical ERYP trend table...|
|Date||Alert Name||Type||% Chg|
|Jan 18||Volume Surge||Other||0.00%|
|Jan 18||Wide Bands||Range Expansion||0.00%|
|Jan 18||Gapped Up||Strength||0.00%|
|Jan 18||Overbought Stochastic||Strength||0.00%|
|Jan 18||Upper Bollinger Band Touch||Strength||0.00%|
|Jan 17||MACD Bullish Centerline Cross||Bullish||3.36%|
|Jan 17||Narrow Range Bar||Range Contraction||3.36%|
|Jan 17||Wide Bands||Range Expansion||3.36%|
|Jan 17||Overbought Stochastic||Strength||3.36%|
|Jan 17||Gapped Down||Weakness||3.36%|
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicatorsBasic chart:
Erytech Pharma SA, also known as ERYTECH Pharma, is a France-based biopharmaceutical company developing medicinal products mainly in oncology, hematology and immunology fields of business. The Company offers ESY-ASP (GRASPA), a medicinal product consisting of L-Asparaginase entrapped into human homologous red blood cells. The product is used for treatment of Acute Lymphoblastic Leukemia (ALL), a childhood cancer. The Company's technology is based on the use of human red blood cells (RBCs) to improve the pharmacokinetic (PK) and pharmacodynamic (PD) properties of therapeutic enzymes, for instance asparaginase. The enzyme can destroy asparagine and deprive cancer cells of an important nutrient for these cells, resulting in their death. The Company's subsidiary is Erytech Pharma, Inc in the USA which legal existence began in April 9, 2014.
|Indicator||Bull Case||Neutral / Hold||Bear Case|
|Oversold / Overbought|
|Summary:||Counts: 1 bullish, 1 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.|
See more ERYP news...
|52 Week High||30.56|
|52 Week Low||5.45|
|200-Day Moving Average||13.6648|
|50-Day Moving Average||7.2262|
|20-Day Moving Average||6.958|
|10-Day Moving Average||7.273|
|Average True Range||0.4727|
|Chandelier Exit (Long, 3 ATRs )||6.951899999999999|
|Chandelier Exit (Short, 3 ATRs )||6.8681|
|Upper Bollinger Band||8.219|
|Lower Bollinger Band||5.697|
|Percent B (%b)||0.91|
|MACD Signal Line||-0.0802|
|Pivot Point Level||Traditional / Classic||Fibonacci||Demark||Woodie||Camarilla|
|Resistance 4 (R4)||8.56|
|Resistance 3 (R3)||8.62||8.49||8.46|
|Resistance 2 (R2)||8.49||8.35||8.46||8.43|
|Resistance 1 (R1)||8.25||8.26||8.19||8.19||8.40|
|Support 1 (S1)||7.88||7.98||7.82||7.82||7.60|
|Support 2 (S2)||7.75||7.89||7.72||7.57|
|Support 3 (S3)||7.51||7.75||7.54|
|Support 4 (S4)||7.45|